Last 12 months
Inside the activity.
1 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2021 Filed Feb 24, 2021 00:37 UTC |
Sabol Colin RSenior Vice President
|
Tax withholdingCommon Stock | 1,581 | $99.48 | $157,277.88 |
DisclosureSEC source: 0001209191-21-013469 · doc4.xml · nonDerivative · entry 4 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,301 F4 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of performance-based restricted stock units granted on Feb 21, 2018 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 00:37 UTC |
Sabol Colin RSenior Vice President
|
GrantCommon Stock | 5,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013469 · doc4.xml · nonDerivative · entry 3 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,882 F3 · shares: Reflects the acquisition of 5,320 shares of common stock upon vesting of performance-based restricted stock units granted on February 21, 2018 upon achievement of performance criteria related to Total Shareholder Return, under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 00:37 UTC |
Sabol Colin RSenior Vice President
|
Tax withholdingCommon Stock | 330 | $99.48 | $32,828.40 |
DisclosureSEC source: 0001209191-21-013469 · doc4.xml · nonDerivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,562 F2 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 21, 2018 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 00:35 UTC |
McShane Geri-MichelleChief Accounting Officer
|
Tax withholdingCommon Stock | 148 | $99.48 | $14,723.04 |
DisclosureSEC source: 0001209191-21-013468 · doc4.xml · nonDerivative · entry 4 McShane Geri-Michelle · CIK 0001769064 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,913 F4 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of performance-based restricted stock units granted on Feb 21, 2018 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 00:35 UTC |
McShane Geri-MichelleChief Accounting Officer
|
GrantCommon Stock | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013468 · doc4.xml · nonDerivative · entry 3 McShane Geri-Michelle · CIK 0001769064 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,061 F3 · shares: Reflects the acquisition of 373 shares of common stock upon vesting of performance-based restricted stock units granted on February 21, 2018 upon achievement of performance criteria related to Total Shareholder Return, under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 00:35 UTC |
McShane Geri-MichelleChief Accounting Officer
|
Tax withholdingCommon Stock | 31 | $99.48 | $3,083.88 |
DisclosureSEC source: 0001209191-21-013468 · doc4.xml · nonDerivative · entry 2 McShane Geri-Michelle · CIK 0001769064 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,688 F2 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 21, 2018 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 00:33 UTC |
Flinton DavidSenior Vice President
|
Tax withholdingCommon Stock | 852 | $99.48 | $84,756.96 |
DisclosureSEC source: 0001209191-21-013465 · doc4.xml · nonDerivative · entry 4 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,691 F4 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of performance-based restricted stock units granted on Feb 21, 2018 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 00:33 UTC |
Flinton DavidSenior Vice President
|
GrantCommon Stock | 2,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013465 · doc4.xml · nonDerivative · entry 3 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,543 F3 · shares: Reflects the acquisition of 2,926 shares of common stock upon vesting of performance-based restricted stock units granted on February 21, 2018 upon achievement of performance criteria related to Total Shareholder Return, under the Xylem 2011 Omnibus Incentive Plan. Read SEC document |
| February 21, 2021 Filed Feb 24, 2021 00:33 UTC |
Flinton DavidSenior Vice President
|
Tax withholdingCommon Stock | 179 | $99.48 | $17,806.92 |
DisclosureSEC source: 0001209191-21-013465 · doc4.xml · nonDerivative · entry 2 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,617 F2 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 21, 2018 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 19:41 UTC |
Toussaint Claudia SSVP, GC & Corporate Secretary
|
Tax withholdingCommon Stock | 357 | $99.48 | $35,514.36 |
DisclosureSEC source: 0001209191-21-013477 · doc4.xml · nonDerivative · entry 1 Toussaint Claudia S · CIK 0001421560 · SVP, GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,709 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 20, 2019 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 19:15 UTC |
Decker PatrickDirector · President & CEO
|
Tax withholdingCommon Stock | 2,215 | $99.48 | $220,348.20 |
DisclosureSEC source: 0001209191-21-013456 · doc4.xml · nonDerivative · entry 1 Decker Patrick · CIK 0001403434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,306 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 20, 2019 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 19:40 UTC |
Tarapore KairusSVP & CHRO
|
Tax withholdingCommon Stock | 304 | $99.48 | $30,241.92 |
DisclosureSEC source: 0001209191-21-013474 · doc4.xml · nonDerivative · entry 1 Tarapore Kairus · CIK 0001383582 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,563 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 20, 2019 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 00:37 UTC |
Sabol Colin RSenior Vice President
|
Tax withholdingCommon Stock | 364 | $99.48 | $36,210.72 |
DisclosureSEC source: 0001209191-21-013469 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,892 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 20, 2019 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 00:35 UTC |
McShane Geri-MichelleChief Accounting Officer
|
Tax withholdingCommon Stock | 67 | $99.48 | $6,665.16 |
DisclosureSEC source: 0001209191-21-013468 · doc4.xml · nonDerivative · entry 1 McShane Geri-Michelle · CIK 0001769064 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,719 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 20, 2019 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 00:33 UTC |
Flinton DavidSenior Vice President
|
Tax withholdingCommon Stock | 232 | $99.48 | $23,079.36 |
DisclosureSEC source: 0001209191-21-013465 · doc4.xml · nonDerivative · entry 1 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,796 F1 · shares: Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 20, 2019 under the Xylem 2011 Omnibus Incentive Plan Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 17:12 UTC |
Sabol Colin RSenior Vice President
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,900 | $0.00 Strike: $37.47 | $0.00 |
DisclosureSEC source: 0001209191-21-004619 · doc4.xml · derivative · entry 7 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,397 Underlying: Common · 1,900 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 17:12 UTC |
Sabol Colin RSenior Vice President
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,900 | $0.00 Strike: $37.47 | $0.00 |
DisclosureSEC source: 0001209191-21-004619 · doc4.xml · derivative · entry 6 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,257 Underlying: Common · 1,900 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 17:12 UTC |
Sabol Colin RSenior Vice President
|
SaleCommon Stock | 1,796 | $104.15 | $187,062.02 |
DisclosureSEC source: 0001209191-21-004619 · doc4.xml · nonDerivative · entry 5 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,256 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,446 shares that were executed at prices ranging from $103.39 to $104.382 per Share. 350 shares were executed at prices ranging from $104.39 to $105.09. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 17:12 UTC |
Sabol Colin RSenior Vice President
|
SaleCommon Stock | 1,900 | $105.00 | $199,500.00 |
DisclosureSEC source: 0001209191-21-004619 · doc4.xml · nonDerivative · entry 4 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,052 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. F3 · price: Shares were sold at an average execution price of $105.00. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 17:12 UTC |
Sabol Colin RSenior Vice President
|
Exercise / conversionCommon Stock | 1,900 | $37.47 | $71,193.00 |
DisclosureSEC source: 0001209191-21-004619 · doc4.xml · nonDerivative · entry 3 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 17:12 UTC |
Sabol Colin RSenior Vice President
|
SaleCommon Stock | 1,900 | $104.15 | $197,893.74 |
DisclosureSEC source: 0001209191-21-004619 · doc4.xml · nonDerivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,052 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,654 shares that were executed at prices ranging from $103.60 to $104.52 per Share. 246 shares were executed at prices ranging from $104.72 to $105.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 17:12 UTC |
Sabol Colin RSenior Vice President
|
Exercise / conversionCommon Stock | 1,900 | $37.47 | $71,193.00 |
DisclosureSEC source: 0001209191-21-004619 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. Read SEC document |
| December 30, 2020 Filed Dec 31, 2020 11:26 UTC |
Toussaint Claudia SSVP, GC & Corporate Secretary
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 21,923 | $0.00 Strike: $35.96 | $0.00 |
DisclosureSEC source: 0001209191-20-065624 · doc4.xml · derivative · entry 3 Toussaint Claudia S · CIK 0001421560 · SVP, GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 21,923 shares Expires 2025-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| December 30, 2020 Filed Dec 31, 2020 11:26 UTC |
Toussaint Claudia SSVP, GC & Corporate Secretary
|
SaleCommon Stock | 21,923 | $100.60 | $2,205,528.34 |
DisclosureSEC source: 0001209191-20-065624 · doc4.xml · nonDerivative · entry 2 Toussaint Claudia S · CIK 0001421560 · SVP, GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,066 F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 21,823 shares that were executed at prices ranging from $100.11 to $101.09 per Share. 100 shares were executed at prices of $101.15. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. F3 · balance_after: 43,469 shares were moved into Ms. Toussaint's Trust established on December 3, 2020. Read SEC document |
| December 30, 2020 Filed Dec 31, 2020 11:26 UTC |
Toussaint Claudia SSVP, GC & Corporate Secretary
|
Exercise / conversionCommon Stock | 21,923 | $35.96 | $788,351.08 |
DisclosureSEC source: 0001209191-20-065624 · doc4.xml · nonDerivative · entry 1 Toussaint Claudia S · CIK 0001421560 · SVP, GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on November 30, 2020 Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 16:47 UTC |
TAMBAKERAS MARKOS IDirector
|
SaleCommon Stock | 5,000 | $99.00 | $495,000.00 |
DisclosureSEC source: 0001209191-20-063817 · doc4.xml · nonDerivative · entry 2 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tambakeras Family Trust Disclosed balance after: 38,062 F2 · price: This price represents the weighted average price per Share of the Issuer. Shares were executed at a price $99.00 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. F1 · balance_after: The reporting officer transferred 6,777.513 shares from his GRAT to the Tambakeras Family Trust on October 16, 2020. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:40 UTC |
Sabol Colin RSenior Vice President
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,196 | $0.00 Strike: $37.47 | $0.00 |
DisclosureSEC source: 0001209191-20-063815 · doc4.xml · derivative · entry 4 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,197 Underlying: Common · 5,196 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:40 UTC |
Sabol Colin RSenior Vice President
|
SaleCommon Stock | 2,067 | $98.31 | $203,201.40 |
DisclosureSEC source: 0001209191-20-063815 · doc4.xml · nonDerivative · entry 3 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,052 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2020. F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 67 shares that were executed at prices ranging from $98.13 to $99.12 per Share. 2,000 shares were executed at prices ranging from $99.13 to $99.36. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:40 UTC |
Sabol Colin RSenior Vice President
|
SaleCommon Stock | 5,196 | $98.31 | $510,805.25 |
DisclosureSEC source: 0001209191-20-063815 · doc4.xml · nonDerivative · entry 2 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,119 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2020. F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,863 shares that were executed at prices ranging from $97.09 to $97.71 per Share. 2,333 shares were executed at prices ranging from $98.13 to $99.12. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:40 UTC |
Sabol Colin RSenior Vice President
|
Exercise / conversionCommon Stock | 5,196 | $37.47 | $194,694.12 |
DisclosureSEC source: 0001209191-20-063815 · doc4.xml · nonDerivative · entry 1 Sabol Colin R · CIK 0001531414 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2020. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 20:44 UTC |
Harker Victoria DDirector
|
SaleCommon Stock | 4,000 | $97.41 | $389,642.80 |
DisclosureSEC source: 0001209191-20-062915 · doc4.xml · nonDerivative · entry 1 Harker Victoria D · CIK 0001350579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,959 F1 · price: This price represents the weighted average price per Share of the Issuer. Shares were sold at prices ranging from $97.0608 to $97.8850. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| November 18, 2020 Filed Feb 1, 2021 15:59 UTC |
LORANGER STEVEN RDirector
|
GiftCommon Stock | 13,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006383 · doc5.xml · nonDerivative · entry 1 LORANGER STEVEN R · CIK 0001226924 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Steven R Loranger Revokable Trust Disclosed balance after: 58,898 F1 · shares: On November 18, 2020, 13,545 shares of Xylem Inc. common stock were transferred from the Steven R Loranger Revocable Trust to the Steve and Betsy Loranger Foundation. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 15:59 UTC |
Tarapore KairusSVP & CHRO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,138 | $0.00 Strike: $33.85 | $0.00 |
DisclosureSEC source: 0001209191-20-057259 · doc4.xml · derivative · entry 3 Tarapore Kairus · CIK 0001383582 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 8,138 shares Expires 2025-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 15:59 UTC |
Tarapore KairusSVP & CHRO
|
SaleCommon Stock | 8,138 | $91.15 | $741,779.51 |
DisclosureSEC source: 0001209191-20-057259 · doc4.xml · nonDerivative · entry 2 Tarapore Kairus · CIK 0001383582 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,867 F1 · price: This price represents the weighted average price per Share of the Issuer. Shares were sold at prices ranging from $91.1450 to $91.1550. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 15:59 UTC |
Tarapore KairusSVP & CHRO
|
Exercise / conversionCommon Stock | 8,138 | $33.85 | $275,471.30 |
DisclosureSEC source: 0001209191-20-057259 · doc4.xml · nonDerivative · entry 1 Tarapore Kairus · CIK 0001383582 · SVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 17:00 UTC |
Rowland Sandra E.Chief Financial Officer
|
GrantStock Option · Derivative | 23,148 | $0.00 Strike: $88.59 | $0.00 |
DisclosureSEC source: 0001209191-20-056833 · doc4.xml · derivative · entry 2 Rowland Sandra E. · CIK 0001629360 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,148 Underlying: Common · 23,148 shares Expires 2030-02-27 F2 · derivative.exercise_date: Reflects an award of stock options which are scheduled to vest in one third increments on February 27, 2021, February 27, 2022 and February 27, 2023. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 17:00 UTC |
Rowland Sandra E.Chief Financial Officer
|
GrantCommon Stock | 4,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056833 · doc4.xml · nonDerivative · entry 1 Rowland Sandra E. · CIK 0001629360 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,797 F1 · shares: Reflects an award of restricted stock units which are scheduled to vest in one third increments on February 27, 2021, February 27, 2022 and February 27, 2023 Read SEC document |
| October 16, 2020 Filed Dec 16, 2020 16:47 UTC |
TAMBAKERAS MARKOS IDirector
|
GiftCommon Stock | 6,777 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-063817 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Tambakeras 2018 Grantor Retained Annuity Trust Disclosed balance after: 0 F1 · shares: The reporting officer transferred 6,777.513 shares from his GRAT to the Tambakeras Family Trust on October 16, 2020. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 16:51 UTC |
TAMBAKERAS MARKOS IDirector
|
SaleCommon Stock | 6,050 | $85.23 | $515,647.55 |
DisclosureSEC source: 0001209191-20-054023 · doc4.xml · nonDerivative · entry 2 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tambakeras Family Trust Disclosed balance after: 36,285 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on September 2, 2020. F3 · price: This price represents the weighted average price per Share of the Issuer. Shares were executed at prices ranging from $85.00 to $85.56 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:53 UTC |
Flinton DavidSenior Vice President
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 11,737 | $0.00 Strike: $48.33 | $0.00 |
DisclosureSEC source: 0001209191-20-054024 · doc4.xml · derivative · entry 10 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 11,737 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These options are fully vested and exercisable as of February 21,2020. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:53 UTC |
Flinton DavidSenior Vice President
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,472 | $0.00 Strike: $37.47 | $0.00 |
DisclosureSEC source: 0001209191-20-054024 · doc4.xml · derivative · entry 9 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 12,472 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options are fully vested and exercisable as of February 24,2019. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:53 UTC |
Flinton DavidSenior Vice President
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,448 | $0.00 Strike: $35.96 | $0.00 |
DisclosureSEC source: 0001209191-20-054024 · doc4.xml · derivative · entry 8 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 6,448 shares Expires 2025-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options are fully vested and exercisable as of February 24,2018. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:53 UTC |
Flinton DavidSenior Vice President
|
SaleCommon Stock | 2,729 | $86.05 | $234,827.45 |
DisclosureSEC source: 0001209191-20-054024 · doc4.xml · nonDerivative · entry 7 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,028 F5 · shares: These shares are sold pursuant to a 10b5-1 plan adopted by the reporting person on September 4, 2020 F6 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,372 shares were executed at prices ranging from $85.39 to $86.36 per Share. 357 shares were executed at prices ranging from $86.39 to $86.46. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:53 UTC |
Flinton DavidSenior Vice President
|
SaleCommon Stock | 11,737 | $86.05 | $1,009,997.02 |
DisclosureSEC source: 0001209191-20-054024 · doc4.xml · nonDerivative · entry 6 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,757 F1 · shares: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan which was adopted on September 4, 2020 F4 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,037 shares were executed at prices ranging from $85.05 to $86.04 per Share. 7,700 shares were executed at prices ranging from $86.05 to $86.52. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:53 UTC |
Flinton DavidSenior Vice President
|
Exercise / conversionCommon Stock | 11,737 | $48.33 | $567,249.21 |
DisclosureSEC source: 0001209191-20-054024 · doc4.xml · nonDerivative · entry 5 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan which was adopted on September 4, 2020 Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:53 UTC |
Flinton DavidSenior Vice President
|
SaleCommon Stock | 12,472 | $86.05 | $1,073,171.95 |
DisclosureSEC source: 0001209191-20-054024 · doc4.xml · nonDerivative · entry 4 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,757 F1 · shares: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan which was adopted on September 4, 2020 F3 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,720 shares were executed at prices ranging from $84.92 to $85.88 per Share. 9,752 shares were executed at prices ranging from $85.925 to $86.45. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:53 UTC |
Flinton DavidSenior Vice President
|
Exercise / conversionCommon Stock | 12,472 | $37.47 | $467,325.84 |
DisclosureSEC source: 0001209191-20-054024 · doc4.xml · nonDerivative · entry 3 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan which was adopted on September 4, 2020 Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:53 UTC |
Flinton DavidSenior Vice President
|
SaleCommon Stock | 6,448 | $86.05 | $554,849.76 |
DisclosureSEC source: 0001209191-20-054024 · doc4.xml · nonDerivative · entry 2 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,757 F1 · shares: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan which was adopted on September 4, 2020 F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,200 shares were executed at prices ranging from $85.04 to $86.03 per Share. 4,248 shares were executed at prices ranging from $86.05 to $86.52. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:53 UTC |
Flinton DavidSenior Vice President
|
Exercise / conversionCommon Stock | 6,448 | $35.96 | $231,870.08 |
DisclosureSEC source: 0001209191-20-054024 · doc4.xml · nonDerivative · entry 1 Flinton David · CIK 0001654800 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,205 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan which was adopted on September 4, 2020 Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 16:51 UTC |
TAMBAKERAS MARKOS IDirector
|
SaleCommon Stock | 700 | $85.00 | $59,502.52 |
DisclosureSEC source: 0001209191-20-054023 · doc4.xml · nonDerivative · entry 1 TAMBAKERAS MARKOS I · CIK 0001012990 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tambakeras Family Trust Disclosed balance after: 42,335 F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on September 2, 2020. F2 · price: This price represents the weighted average price per Share of the Issuer. Shares were executed at a price $85.0036 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.